Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Novartis to Close Sandoz Facility | Contract Pharma

What are you searching for?

Sign in
Breaking News

Novartis to Close Sandoz Facility

To discontinue and/or divest several generic products facing pricing pressures

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

Novartis plans to close a Sandoz generics manufacturing facility in Broomfield, CO that will result in the loss of approximately 450 jobs over the next couple of years. The company plans to discontinue and/or divest several products with limited growth potential, specifically those facing pricing pressures in the U.S.
 
The products include oral generic treatments in cardiology, central nervous system, endocrinology, respiratory and pain. 
 
The phased closure and transfer of some operations to a Sandoz facility in North Carolina is scheduled to be completed in late 2019.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters